
SomaLogic, Inc.
SLGCNASDAQHealthcare
$2.10
$-0.10(-4.55%)
Market Cap$396225917
P/E Ratio—
52W High$3.79
52W Low$1.73
SomaLogic, Inc.(SLGC)股票概览
关键指标与盈利、估值、营收、股息等标签页深链。
FMP · SLGC · 截至 Jun 9, 2026
关键指标
探索 SomaLogic, Inc. 数据
slgc stock data · financials竞争对手与同行
slgc competitors#TickerCompanyPriceChangeMkt Cap
#1SomaLogic, Inc.
$2.10-4.55%$396.2M#2Accolade, Inc.
$7.02+0.00%$575.6M#3Checkpoint Therapeutics, Inc.
$4.26+0.00%$367.7M#4Global Cord Blood Corporation
$0.95+0.00%$127.2M#5Claritev Corporation
$27.07+4.76%$461.5M#6G1 Therapeutics, Inc.
$7.16+0.14%$377.7M关于 SomaLogic, Inc.
SomaLogic, Inc. is a U.S.-based enterprise specializing in the identification of protein biomarkers and the development of clinical diagnostic solutions. A core aspect of its technology involves the c…
what is somalogic, inc. · slgc stock overview · somalogic, inc. company profile · who is somalogic, inc. ceo · slgc NASDAQ · somalogic, inc. headquarters · somalogic, inc. business segments
关于股票概览与关键数据
SomaLogic, Inc.(SLGC)是 Medical - Healthcare Information Services 行业的 Healthcare 类公司,于 Apr 23, 2021 在 NASDAQ 上市。截至最近交易日,SLGC 股价为 $2.10,市值约为 $396.2M。过去12个月累计回报 —,年初至今回报 —。
常见问题
截至最近一个交易日,SomaLogic, Inc.(SLGC)股价为 $2.10,在 NASDAQ 上市,52周区间为 $1.73 – $3.79。
SLGC 最新股价SLGC quote todaylive ticker 实时行情
数据来源:Financial Modeling Prep最后更新:Jun 9, 2026本内容不构成投资建议